ITRI.NASDAQItron, INC

Form 4: Itron CEO Thomas Deitrich Executes Stock Transactions Under 10b5-1 Plan

Sentiment:

SEC Form 4 Filing


Itron's CEO, Thomas Deitrich, exercised stock options and sold shares under a pre-arranged 10b5-1 trading plan on January 2, 2025.

Summary

  • Thomas Deitrich, President and CEO of Itron, Inc., executed transactions involving the company's common stock on January 2, 2025.
  • These transactions included the exercise of 2,954 stock options at a price of $35.13 per share and the subsequent sale of 2,954 shares at a weighted average price of $110.11.
  • The sales were executed under a Rule 10b5-1 trading plan adopted on May 6, 2024.
  • The shares were sold in multiple transactions with prices ranging from $110.00 to $110.23.
  • Following these transactions, Mr. Deitrich directly owns 204,393 shares of Itron common stock and indirectly owns 25,000 shares through a trust.
  • He also holds 34,787 stock options.

Sentiment

Score: 5

Explanation: The document reflects routine insider trading activity under a pre-arranged plan, which is neither positive nor negative for the company's outlook.

Positives

  • The transactions were executed under a pre-arranged 10b5-1 trading plan, which is a common practice for executives to avoid accusations of insider trading.
  • The exercise of options and subsequent sale of shares indicates that the CEO is taking advantage of the current stock price.

Negatives

  • The sale of shares by the CEO could be interpreted negatively by some investors, although it is part of a pre-planned strategy.

Risks

  • There is a risk that the market may react negatively to the CEO selling shares, even if it is part of a pre-planned trading plan.
  • The market may interpret the sale as a lack of confidence in the company's future performance.

Industry Context

This is a routine filing related to insider trading activity and is common for publicly traded companies. It does not indicate any specific trend in the industry.

Comparison to Industry Standards

  • The use of a 10b5-1 trading plan is a standard practice among executives at publicly traded companies to manage their stock transactions and avoid insider trading accusations.
  • The reported transactions are typical for executives who receive stock options as part of their compensation.

Stakeholder Impact

  • The transactions may have a minor impact on shareholders, as the sale of shares by the CEO could be perceived negatively by some investors.

Key Dates

DateDescription
2018-12-10The stock options exercised by Mr. Deitrich became fully vested.
2024-05-06Mr. Deitrich adopted a Rule 10b5-1 Trading Plan.
2025-01-02Mr. Deitrich exercised stock options and sold shares.
2025-01-03The Form 4 was signed by Christopher E. Ware, attorney-in-fact.
2025-12-10Expiration date of the stock options exercised.

Keywords

insider trading, stock options, 10b5-1 plan, executive compensation, share sale, ITRI, Itron, Thomas Deitrich

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.